Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Short-term Investments (2017 - 2025)

Inspire Medical Systems (INSP) has disclosed Short-term Investments for 9 consecutive years, with $203.5 million as the latest value for Q4 2025.

  • Quarterly Short-term Investments fell 31.12% to $203.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $203.5 million through Dec 2025, down 31.12% year-over-year, with the annual reading at $203.5 million for FY2025, 31.12% down from the prior year.
  • Short-term Investments hit $203.5 million in Q4 2025 for Inspire Medical Systems, down from $209.7 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $315.3 million in Q1 2025 to a low of $9.7 million in Q3 2022.
  • Historically, Short-term Investments has averaged $157.7 million across 5 years, with a median of $198.7 million in 2025.
  • Biggest five-year swings in Short-term Investments: plummeted 68.84% in 2022 and later skyrocketed 2698.47% in 2023.
  • Year by year, Short-term Investments stood at $31.3 million in 2021, then plummeted by 68.62% to $9.8 million in 2022, then surged by 2698.47% to $274.8 million in 2023, then rose by 7.48% to $295.4 million in 2024, then tumbled by 31.12% to $203.5 million in 2025.
  • Business Quant data shows Short-term Investments for INSP at $203.5 million in Q4 2025, $209.7 million in Q3 2025, and $194.0 million in Q2 2025.